Dr Sam Moxon, narrates his blog written for NIHR Dementia Researcher.
If you're a member of the public, you may think Aducanumab is the miracle dementia drug we've been waiting for, so why do many researchers disagree? Dr Sam Moxon explores in this blog.
Find the original text, and narration here on our website.
http://www.dementiaresearcher.nihr.ac.uk